Case Report: response of HER2-positive ductal carcinoma in situ to osimertinib with supporting in vitro evidence.
- DOI
- 10.3389/fonc.2026.1845658
- Published
- 2026
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1845658,
title = {Case Report: response of HER2-positive ductal carcinoma in situ to osimertinib with supporting in vitro evidence.},
author = {Baba S and Koketsu M and Kuroda H and Suzuki M and Nishihara H and Kato Y and Kawami H and Harada O},
year = {2026},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2026.1845658},
url = {https://doi.org/10.3389/fonc.2026.1845658}
}RIS
TY - JOUR TI - Case Report: response of HER2-positive ductal carcinoma in situ to osimertinib with supporting in vitro evidence. AU - Baba S AU - Koketsu M AU - Kuroda H AU - Suzuki M AU - Nishihara H AU - Kato Y AU - Kawami H AU - Harada O PY - 2026 JO - Frontiers in oncology DO - 10.3389/fonc.2026.1845658 UR - https://doi.org/10.3389/fonc.2026.1845658 ER -
APA
S, B., M, K., H, K., M, S., H, N., Y, K., H, K., & O, H. (2026). Case Report: response of HER2-positive ductal carcinoma in situ to osimertinib with supporting in vitro evidence.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1845658